Topic Hub

Tesamorelin — Regulatory History

2 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.

2articles

21keywords mapped

2026-05-26latest review

Explore

Tesamorelin — Regulatory History library

Showing 2 of 2 clinical reviews.

Clinical Reviews2026-05-26

Egrifta (Tesamorelin) Compounding Legal Status: FDA Approval, Label Details, and Current Regulatory Standing

A clinical overview of tesamorelin (Egrifta) compounding legality, FDA approval history, shortage designations, and what patients and providers need to know about access in 2026.

Read clinical review

Safety2026-05-26

Egrifta (Tesamorelin) Label Updates 2020-2026: FDA Changes, Safety Signals, and What Prescribers Need to Know

A detailed review of all FDA label changes for Egrifta and Egrifta SV (tesamorelin) from 2020 through 2026, including updated warnings, post-marketing safety data, and clinical guidance.

Read clinical review